Document Download Tool

Personalized Document Selection & Download

Corporate Governance Declaration of Conformity 2023
Transcript Q2 2023 Investor Webinar 2023-08-08
Transcript Bayer Pharmaceuticals R&D Event 2023
Transcript Q1 2023 Investor Conference Call 2023-05-11
Transcript FY/Q4 2022 Investor Conference Call 2023-02-28
Transcript Q3 2022 Investor Conference Call 2022-11-08
Transcript Consumer Health Investor Webinar September 2022
Transcript Asundexian Investor Webinar August 2022
Transcript Q2 2022 Investor Conference Call 2022-08-04
Transcript Q1 2022 Investor Conference Call 2022-05-10
Transcript FY Q4 2021 Investor Conference Call 2022-03-01
Transcript Nubeqa Investor Webinar February 2022
Corporate Governance Declaration of Conformity 2021
Transcript Finerenone Investor-Webinar November 2021
Transcript Q3 2021 Investor Conference Call 2021-11-09
Transcript Crop Science Investor Webinar October 2021
Transcript Q2 2021 Investor Conference Call 2021-08-05
Transcript Q1 2021 Investor Conference Call 2021-05-12
Transcript FY Q4 2020 Investor Conference Call 2021-02-25
Corporate Governance Declaration of Conformity 2020
Transcript Q3 2020 Investor Conference Call 2020-11-03
Transcript Investor Conference Call 2020-09-30, Bayer to accelerate transformation
Transcript ESG Investor Conference Call 2020-09-17
Transcript Q2 2020 Investor Conference Call 2020-08-04
Transcript Investor Conference Call 2020-06-25, Q&A
Transcript Investor Conference Call 2020-06-24, Q&A
Transcript Q1 2020 Investor Conference Call 2020-04-27
Transcript FY Q4 2019 Investor Conference Call 2020-02-27
Transcript Crop Science R&D Pipeline Update Call 2020-02-13
Corporate Governance Declaration of Conformity 2019
Transcript Investor Conference Call 2019-12-10, Bayer 2030 Sustainable Development Objectives
Transcript Q3 2019 Investor Conference Call 2019-10-30
Transcript Crop Science Summer Technology Showcase August 1, 2019
Transcript Q2 2019 Investor Conference Call 2019-07-30
ASM 2019 Summary Habersack Legal Opinion Management Board Duties Monsanto Acquisition
ASM 2019 Summary Linklaters Legal Opinion Management Board Duties Monsanto Acquisition
ASM 2019 Subsidiary and affiliated companies of the Bayer Group 2018
ASM 2019 Statement regarding ISS' and Glass Lewis' voting recommendations
ASM 2019 Statement of the Board of Management and the Supervisory Board on the Countermotions
ASM 2019 Report by the Board of Management on Agenda Item 5
ASM 2019 Information on Stockholders’ Rights
ASM 2019 Privacy Information for Attendees
Transcript Q1 2019 Investor Conference Call 2019-04-25
Transcript FY/Q4 2018 Investor Conference Call 2019-02-27
Transcript CMD 2018-12-05 Morning Presentations and Q&A
Transcript CMD 2018-12-05 Crop Science World Class Innovation Platform
Transcript CMD 2018-12-05 Crop Science Introduction to Agriculture
Transcript CMD 2018-12-05 Crop Science Excellence in Commercial Integration and Execution
Transcript CMD 2018-12-05 Crop Science Advancing the Digital Transformation
Transcript Q3 2018 Investor Conference Call 2018-11-13
Transcript Q2 2018 Investor Conference Call 2018-09-05
Transcript Investor Conference Call 2018-08-23, Discussion Glyphosate Litigation
ASM 2018 Countermotions and election proposals
ASM 2018 Update of the proposed resolution regarding Item 1
ASM 2018 Subsidiary and affiliated companies of the Bayer Group 2017
ASM 2018 Report of the Board of Management regarding the utilization of the Authorized Capital II
Transcript Q1 2018 Investor Conference Call 2018-05-03
Transcript FY/Q4 2017 Investor Conference Call 2018-02-28
Transcript Q3 2017 Investor Conference Call 2017-10-26
Transcript Investor Conference Call Xarelto COMPASS Data at ESC Congress 2017-08-28
Transcript Q2 2017 Investor Conference Call 2017-07-27
ASM 2018 Explanation of Stockholder Rights
ASM 2017 Financial Statements of Bayer CropScience AG 2016
ASM 2017 Financial Statements of Bayer CropScience AG 2015
ASM 2017 Financial Statements of Bayer CropScience AG 2014
ASM 2017 Financial Statements of Bayer AG 2016
ASM 2017 Financial Statements of Bayer AG 2015
ASM 2017 Financial Statements of Bayer AG 2014
ASM 2017 Control agreement between the Company and Bayer CropScience AG
ASM 2017 Financial Statements of Bayer AG 2016
ASM 2017 Subsidiary and affiliated companies of the Bayer Group 2016
ASM 2017 Explanation of Stockholder Rights
ASM 2017 Countermotions and election proposals
ASM 2017 Articles of Incorporation (as of June 5, 2015)
Transcript Q1 2017 Investor Conference Call 2017-04-27
Transcript Meet Management 2017-03-15, Presentations
Transcript FY/Q4 2016 Investor Conference Call 2017-02-22
ASM 2016 Countermotions and election proposals
ASM 2016 Financial Statements of Bayer AG 2015
ASM 2016 Subsidiary and affiliated companies of the Bayer Group as of December 31, 2015
ASM 2016 Explanation of Stockholder Rights